PDL BioPharma, Inc. (PDLI) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total non-operating expense, net: -4.35M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q4 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $72.81 million versus the consensus estimate of $72.85 million.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
